Tessa Therapeutics Company
Tessa Therapeutics is a provider of therapy designed to focus on T cell therapy for solid tumors.
Technology:
CAR-T therapy, Regenerative Medicine
Industry:
Biotechnology, Health Care, Private, Therapeutics
Headquarters:
Singapore, Central Region, Singapore
Founded Date:
2001-01-01
Employees Number:
101-250
Funding Status:
Early Stage Venture
Investors Number:
7
Total Funding:
256000000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2022-06-09
Last Funding Type:
Series A
Register and Claim Ownership